021-51111890
购物车（）
sales@molnova.cn
BDC2.5 mimotope 1040-31
CAS No. 329696-49-3
BDC2.5 mimotope 1040-31 ( —— )
产品货号. M30240 CAS No. 329696-49-3
This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BDC2.5 mimotope 1040-31
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.
-
产品描述This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number329696-49-3
-
分子量1348.61
-
分子式C63H97N17O14S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:{Tyr}{Val}{Arg}{Pro}{Leu}{Trp}{Val}{Arg}{Met}{Glu}
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Dai YD, et al. A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas. J Immunol. 2005 Sep 15;175(6):3621-7.
产品手册
关联产品
-
Quercetin-3-O-D-gluc...
Quercetin-3-OD-glucosyl]-(1-2)-L-rhamnoside 是舒血宁中药注射液的主要抗氧化剂。
-
BRD0418
BRD0418 是一种调节三元假激酶1 (TRIB1) 表达的多样化综合 (DOS) 分子。BRD0418 具有导致热脂蛋白代谢从脂肪生成到清除的作用。BRD0418 可用于冠状动脉疾病 (CAD) 的研究。
-
Eldacimibe
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
